GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Beginning Cash Position

Veritas In Silico (TSE:130A) Beginning Cash Position : 円0.0 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Beginning Cash Position?

Veritas In Silico's Beginning Cash Position for the quarter that ended in Jun. 2024 was 円0.0 Mil.

Veritas In Silico's annual Beginning Cash Position increased from Dec. 2021 (円521.0 Mil) to Dec. 2022 (円1,688.8 Mil) but then declined from Dec. 2022 (円1,688.8 Mil) to Dec. 2023 (円1,484.4 Mil).

Veritas In Silico Beginning Cash Position Historical Data

The historical data trend for Veritas In Silico's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Beginning Cash Position Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23
Beginning Cash Position
521.02 1,688.76 1,484.43

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24
Beginning Cash Position Get a 7-Day Free Trial - - - - -

Veritas In Silico Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Veritas In Silico Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Beginning Cash Position
Comparable Companies
TSE:4584 TSE:4598 TSE:4570 TSE:4594 TSE:4572 TSE:4884 TSE:4881 TSE:4576 TSE:4591 TSE:2385 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Website
https://www.veritasinsilico.com
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines